XML 70 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants
9 Months Ended
Sep. 30, 2013
Text Block [Abstract]  
Warrants

Note 12—Warrants

The Company accounts for stock warrants as either equity instruments or derivative liabilities depending on the specific terms of the warrant agreement. Stock warrants are accounted for as a derivative in accordance with Financial Accounting Standards Board Accounting Standard Codification (ASC) 815, Derivatives and Hedging (ASC 815) if the stock warrants contain “down-round protection” and therefore, do not meet the scope exception for treatment as a derivative. Since “down-round protection” is not an input into the calculation of the fair value of the warrants, the warrants cannot be considered indexed to the Company’s own stock which is a requirement for the scope exception as outlined under ASC 815. The Company will continue to classify the fair value of the warrants that contain “down-round protection” as a liability until the warrants are exercised, expire or are amended in a way that would no longer require these warrants to be classified as a liability. From January 1, 2012 through September 30, 2012, the Company utilized the Monte Carlo simulation valuation method to value the liability classified warrants. Beginning October 1, 2012, the Company concluded that the Black-Scholes option pricing model was an appropriate valuation method due to the assumption that no future financing would be expected at a price lower than the current exercise price and the majority of the warrants were converted to equity-classified warrants on October 9, 2012.

The following table summarizes outstanding warrants to purchase common stock as of September 30, 2013 and December 31, 2012:

 

     Number of Warrants                

Liability-classified warrants

   As of
September 30,
2013
     As of December 31,
2012
     Exercise
Price
     Expiration Dates  

Issued in Series B Preferred Stock offering

     1,320         1,320       $ 2.50         Jul. – Nov. 2015   

Issued in Series D Preferred Stock offering

     14,800         39,800       $ 2.50         Dec. 2015 – Mar. 2016   

Issued in Series E Preferred Stock offering

     60,000         120,000       $ 2.50         May – June 2017   
  

 

 

    

 

 

       

Subtotal

     76,120         161,120         
  

 

 

    

 

 

       

Equity-classified warrants

                           

Issued in June 2011 equity financing

     6,113         6,113       $ 22.50         June 2016   

Issued in March 2010 and Preferred Stock offerings

     4,209,357         4,209,357       $ 6.25 – 7.50         Oct. 2015 – June 2018   

Issued with Convertible Notes

     1,125,578         1,125,578       $ 2.50         June 2018   

Issued to placement agents in August 2011 equity financing

     50,123         50,123       $ 13.75         August 2016   

Issued in August 2011 equity financing

     565,759         579,759       $ 18.75         August 2016   
  

 

 

    

 

 

       

Subtotal

     5,956,930         5,970,930         
  

 

 

    

 

 

       

Total

     6,033,050         6,132,050         
  

 

 

    

 

 

       

There were 75,000 and 85,000 warrants exercised for the three and nine months ended September 30, 2013, respectively.

Liability-classified Warrants

The following table summarizes the calculated aggregate fair values as of the dates indicated along with the assumptions utilized in the Black-Scholes option pricing model for each calculation.

 

     September 30,
2013
    December 31,
2012
 

Calculated aggregate value (in thousands)

   $ 205      $ 374   

Exercise price per share of warrant

   $ 2.50      $ 2.50   

Closing price per share of common stock

   $ 4.38      $ 3.75   

Volatility

     68     70

Expected term (years)

     3.4        4.0   

Risk-free interest rate

     0.8     0.6

Dividend yield

     —       —